Laparoscopic gastrectomy for heart failure patients with left ventricular assist devices.
gastric cancer
heart failure
laparoscopic surgery
Journal
Asian journal of endoscopic surgery
ISSN: 1758-5910
Titre abrégé: Asian J Endosc Surg
Pays: Japan
ID NLM: 101506753
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
30
05
2019
revised:
23
02
2020
accepted:
12
05
2020
pubmed:
23
6
2020
medline:
28
8
2021
entrez:
23
6
2020
Statut:
ppublish
Résumé
Left ventricular assist devices (LVADs) currently play an important role in the treatment of patients with end-stage heart failure who require a bridge to heart transplantation. As the LVAD population increases, the incidence of cancer patients with an LVAD is assumed to be increasing as well. For gastric cancer patients with an LVAD, surgery may be the only curative treatment, especially as chemotherapy is scarcely available. However, we cannot perform an upper-middle incision in these patients because of the LVAD's location and driveline. Furthermore, to reduce the risk of driveline infection, minimally invasive surgery is desirable. Therefore, laparoscopic surgery is, where possible, suitable for achieving a secure approach to the abdominal cavity. However, laparoscopic surgery for patients with LVAD requires careful consideration not only for anesthetic management, but also for the technical procedure. We ingenuously performed laparoscopic gastrectomy for a gastric cancer patient with LVAD to preserve the device and obtain a good surgical view.
Types de publication
Case Reports
Langues
eng
Sous-ensembles de citation
IM
Pagination
81-84Informations de copyright
© 2020 Japan Society for Endoscopic Surgery, Asia Endosurgery Task Force and John Wiley & Sons Australia, Ltd.
Références
Kirklin JK, Naftel DC, Kormos RL, et al. Fifth INTERMACS annual report: risk factor analysis from more than 6,000 mechanical circulatory support patients. J Heart Lung Transplant. 2013;32(2):141-156.
Wickline SA, Fischer KC. Can infections be imaged in implanted devices? ASAIO J. 2000;46(6):S80-S81.
Pereda D, Conte JV. Left ventricular assist device driveline infections. Cardiol Clin. 2011;29(4):515-527.
Goldstein DJ, Mullis SL, Delphin ES, et al. Noncardiac surgery in long-term implantable left ventricular assist-device recipients. Ann Surg. 1995;222(2):203-207.
Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17(12):3077-3079.
Morgan JA, John R, Rao V, et al. Bridging to transplant with the HeartMate left ventricular assist device: the Columbia Presbyterian 12-year experience. J Thorac Cardiovasc Surg. 2004;127(5):1309-1316.
Nakamura Y, Toda K, Nakamura T, et al. Curative surgery for gastric cancer in a patient with an implantable left ventricular assist device. J Artif Organs. 2017;20(2):170-173.
Abo-Alhassan F, Trilling B, Sage PY, Girard E, Faucheron JL. Feasibility and safety of laparoscopic colorectal surgeries for patients with left ventricular assist device. Int J Colorectal Dis. 2019;34(11):1979-1982.